Defunct Company
Total Trials
4
As Lead Sponsor
As Collaborator
0
Total Enrollment
24
NCT04758949
FL-101 in Surgically Resectable Non-Small Cell Lung Cancer
Phase: Phase 2
Role: Lead Sponsor
Start: Aug 25, 2021
Completion: Dec 22, 2021
NCT04983732
A Bioavailability Study of FL-101 in Healthy Male and Female Subjects
Phase: Phase 1
Start: Sep 11, 2021
Completion: May 5, 2022
NCT05181865
Phase 1/2a Study to Evaluate FL-301 in Patients With Advanced Solid Tumors
Phase: Phase 1/2
Start: Jan 31, 2022
Completion: Jan 18, 2022
NCT05395260
FL- 101 Study in Non-Metastatic MIBC
Phase: Early Phase 1
Start: Aug 22, 2022
Completion: Dec 28, 2022